A Canadian single-centre experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for abdominal malignancies.

Can J Surg · 2022 · PMC9188801 · PMID 35580884

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In patients with PMCA, intraperitoneal HIPEC with oxaliplatin showed a trend toward better DFS and OS, although this was not statistically significant, when compared with intra-abdominal use of mitomycin C ( p = 0.28 for DFS and p = 0.33 for OS).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.